targeted therapy
Stay on Target: Overcoming Challenges in Precision Drug Delivery
The Scientist and Taconic | Oct 24, 2024 | 1 min read
Explore how on-target precision therapies improve patient outcomes and drug tolerability.
Targeting the Undruggable
The Scientist | May 8, 2023 | 1 min read
Through a combination of basic science research and clinical trials, researchers uncover innovative approaches for targeted cancer treatment.
Engineered Cell Libraries for Targeted Therapeutics Development
Synthego | Aug 9, 2022 | 1 min read
Overcome drug resistance by targeting host proteins.
Imaging Technology for Targeted Therapeutic Development
LI-COR | Mar 8, 2022 | 1 min read
Streamlining drug development workflows with cell, tissue, and small animal imagers
Cross-Resistance: One Cancer Therapy Can Undermine the Next
Sophie Fessl, PhD | Jul 16, 2021 | 6 min read
Targeted cancer therapy may jeopardize the effectiveness of subsequent immunotherapy by reducing dendritic cell numbers and activation, according to study of mice and patient samples.
Mutant RAS Proteins Team Up for Oncogenicity
Jim Daley | Apr 1, 2018 | 2 min read
Mice with cancer whose KRAS proteins couldn’t link together had much better survival outcomes than those whose oncogenic mutant paired with wild-type KRAS.
Clinical Matchmaker
Kate Yandell | Jun 1, 2015 | 8 min read
Enrolling the right patient population could be key to a successful clinical trial.